TCM enters into non-exclusive licensing agreement with FITT

15 Jun 2020 Evaluate

TCM has entered into a non-exclusive licensing agreement with Foundation for Innovation and Technology Transfer (FITT), a registered society under the Societies Registration Act 1860, established by the Indian Institute of Technology, Delhi (IIT-Delhi) with respect to KNOWHOW for commercial purpose that includes designing, manufacturing and sales as per the terms and conditions of this agreement of 'Novel Primer set for molecular diagnostic of SARS-CoV-2', that is for the diagnosis of and screening for the COVID-19 using one step RT-qPCR method on all India basis for a period of 5 years effective from June 12, 2020. FITT will provide the technical support for implementation of the License. The Technology is developed by IIT-Delhi and owns the know how in the Technology.

TCM is engaged in the manufacture of Potassium Chlorate - a vital raw material for the match Industry.

TCM Share Price

69.52 -2.78 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×